FDA Releases Draft Guidance for Industry on Chronic Cutaneous Ulcer and Burn Wounds Treatment Products

Summary

The Food and Drug Administration (FDA) has made available a draft guidance document, titled 'Chronic Cutaneous Ulcer and Burn Wounds--Developing Products for Treatment,' which provides recommendations for the development of medications and biological products intended to treat various types of ulcers and burn wounds.